GlassScriptPhysician profile
Rosalind Bowles
NPI 1821004680
$167,709.61
in general payments reported to CMS, 2019-2025
3 companies · $8,898 in 2025
The $8,898 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $28K · 2021: $25K · 2022: $25K · 2023: $34K · 2024: $29K · 2025: $8,898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $69K · Travel and Lodging: $2,281 · Food and Beverage: $25.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $69,008.18 |
| Travel and Lodging | $2,281.09 |
| Food and Beverage | $25.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $149,321.86 | 2020-2025 | |
| Shire North American Group INC | $18,367.80 | 2019 | |
| Novo Nordisk INC | $19.95 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosalind Bowles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.